Novo-Nordisk's "miracle weight-loss drug" has been approved domestically, waiting to explode onto the multi-billion dollar market! How to capture this wave of "weight-loss fever"?
With the relentless competition among pharmaceutical research and development companies, the indications for GLP-1 are expected to continuously expand, and institutions are also constantly revising their expectations for the market size of weight-loss drugs.
ETFs Bet High On Weight Loss Drugs, But Industry Observers Question Long-Term Potential
Wall Street issuer creates “Lucky 8” Chinese giant ETF to target the “Seven Heroes” of US stock technology
① According to the document, the initial members of “Lucky Eight” were Tencent Holdings, Alibaba, Meituan, BYD, and Xiaomi, Pinduoduo, JD, and Baidu; ② Although some China Internet ETFs have provided exposure, Mazza hopes investors can focus on a few key targets in this field.
New Weight Loss ETF Is Essentially A Play On Eli Lilly, Novo Nordisk
South Park Took On Crypto, AI Previously: Animated Comedy Targets Weight-Loss Drug Ozempic Next
EXCLUSIVE: Roundhill Investments Launches Weight Loss ETF For Exposure To Blockbuster Drugs Like Ozempic